Literature DB >> 31610257

Dietary administration of β-caryophyllene and its epoxide to Sprague-Dawley rats for 90 days.

Maria Bastaki1, Anne Marie Api2, Michel Aubanel3, Mark Bauter4, Thierry Cachet5, Jan C R Demyttenaere6, Maodo Malick Diop7, Christie L Harman8, Shim-Mo Hayashi9, Gerhard Krammer10, Vivian Lu1, Palma Ann Marone4, Odete Mendes4, Kevin J Renskers11, Jürgen Schnabel12, Sai Yee Tsang2, Sean V Taylor13.   

Abstract

Two independent 90-day GLP-compliant studies were conducted in Sprague-Dawley rats with β-caryophyllene or β-caryophyllene epoxide, two common flavoring and fragrance materials. Dietary concentrations of β-caryophyllene were 3500; 7000; and 21,000 ppm for males and 3500; 14,000; and 56,000 ppm for females. Dietary concentrations of β-caryophyllene epoxide were 1750; 10,500; and 21,000 ppm. There were no deaths or clinical toxicity attributable to either substance administration. Statistically significant, dose-dependent reductions in body weight, body weight gain, food consumption, and food efficiency at the highest dietary concentrations of β-caryophyllene, but not of β-caryophyllene epoxide, were attributed to palatability issues. Neither β-caryophyllene nor β-caryophyllene epoxide influenced estrus cyclicity or sperm parameters. Macroscopic and microscopic findings were primarily related to changes in the kidneys of male rats, consistent with α2u-globulin nephropathy, and in the liver of male and female rats, including hepatocyte hypertrophy at the middle and high intake levels. These changes correlated with increased absolute and relative organ weights. Since the kidney findings were a species- and sex-specific effect, the NOAEL in each study was based on hepatocyte hypertrophy at the two highest dietary concentrations and were determined to be 222 mg/kg bw/day for β-caryophyllene and 109 mg/kg bw/day for β-caryophyllene epoxide.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  FEMA GRAS; Flavoring ingredient; Fragrance material; Toxicity study; β-caryophyllene; β-caryophyllene epoxide

Mesh:

Substances:

Year:  2019        PMID: 31610257     DOI: 10.1016/j.fct.2019.110876

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  4 in total

1.  Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS).

Authors:  Yvonne Mödinger; Katharina Knaub; Tanita Dharsono; Roland Wacker; Remo Meyrat; M Hunter Land; Anthony L Petraglia; Christiane Schön
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

2.  Terpenes Combinations Inhibit Biofilm Formation in Staphyloccocus aureus by Interfering with Initial Adhesion.

Authors:  Claudia Salinas; Gladys Florentín; Fátima Rodríguez; Nelson Alvarenga; Rosa Guillén
Journal:  Microorganisms       Date:  2022-07-28

3.  Potentiation of Low-Dose Doxorubicin Cytotoxicity by Affecting P-Glycoprotein through Caryophyllane Sesquiterpenes in HepG2 Cells: an in Vitro and in Silico Study.

Authors:  Antonella Di Sotto; Hamid Irannejad; Margherita Eufemi; Romina Mancinelli; Lorena Abete; Caterina Loredana Mammola; Fabio Altieri; Gabriela Mazzanti; Silvia Di Giacomo
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

Review 4.  Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications.

Authors:  Hebaallah Mamdouh Hashiesh; Mohamed F Nagoor Meeran; Charu Sharma; Bassem Sadek; Juma Al Kaabi; Shreesh K Ojha
Journal:  Nutrients       Date:  2020-09-28       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.